“…The expected regular cross-β fibrillar form produced by other PSMs (structural) and PSMα3’s multifaceted pathogenicity on the human body (functional) drives the motivation behind the recent curiosity about this bacterial functional amyloid. Limited, yet seminal, works have bubbled up to rationalize the observed functionalities of PSMα3 based on its structure, e.g., characterization of the monomeric state, factors stabilizing the mature fibril, − the kinetics of aggregation, − nature/location-, − length-, − structure-, , and phase-specific ,,, roles of the constituting residues in diverse functionalities of the peptide, and membrane interaction with PSMα3. , However, the nascent phase of the research is filled with contradictory observations producing inconclusive inferences on the structure of the fibrillar state, ,,,, the factors required for cytotoxicity, − ,,,− sequence/structure-encoded functional specificity, and salt concentration dependence of the structure–toxicity relationship. , The lack of a comprehensive description of the deleterious aggregation process has motivated the present study, which focuses on the switching of specific roles of the charged and the hydrophobic residues at different stages of the aggregation pathway by a comparative kinetic–thermodynamic analysis between the wild-type (WT) PSMα3 sequence and three designed variants with isoleucine to model operatively increased hydrophobicity (WT → IMT, F/V/L < I), glutamine to model lack of charge with comparable hydrophilicity (WT → QMT, D/E/K ≈ Q), and proline to model moderately less hydrophilicity with one less charged residue (WT → PMT, D > P) mutations (see Supporting Information, justification behind the modeling of noncanonical mutants, Figures S1 and S2) at a low salt concentration (see Supporting Information, rationalization behind the choice of low salt concentration).…”